End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care

References

• Finnish Cancer Registry [Internet]. Finland; 2021 [cited 2021 Jan 27]. Available from: http://cancerregistry.fi/
   Google Scholar
• Castro C, Boseti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol. 2014;25(1):283–290.
   PubMed Web of Science ®Google Scholar
• Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6(11):864–870.
   PubMed Web of Science ®Google Scholar
• Janunger KG, Hafström L, Nygren P, SBU-Group, Swedish Council of Technology Assessment in Health Care, et al. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol. 2001;40(2–3):309–326.
   PubMed Web of Science ®Google Scholar
• Coupland VH, Lagergren J, Lüchtenborg M, et al. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut. 2013;62(7):961–966.
   PubMed Web of Science ®Google Scholar
• Murad AM, Santiago FF, Petroianu A, et al. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993;72(1):37–41.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ekström K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8(2):163–168.
   PubMed Web of Science ®Google Scholar
• Jung H-K, Tae CH, Lee H-A, Korean College of Helicobacter and Upper Gastrointestinal Research, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLOS One. 2020;15(4):e0231456.
   PubMed Web of Science ®Google Scholar
• Pyrhönen S, Kuitunen T, Nyandoto P, et al. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71(3):587–591.
   PubMed Web of Science ®Google Scholar
• Chau I, Fuchs CS, Ohtsu A, et al. Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: exploratory analysis of RAINBOW and REGARD phase III trials. Eur J Cancer. 2019;107:115–123.
   PubMed Web of Science ®Google Scholar
• Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 2000;88(8):1781–1787.
   PubMed Web of Science ®Google Scholar
• O'Neill L, Moran J, Guinan EM, et al. Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review. J Cancer Surviv. 2018;12(4):601–618.
   PubMed Web of Science ®Google Scholar
• Kern K, Norton J. Cancer cachexia. JPEN J Parenter Enteral Nutr. 1988;12(3):286–298.
   PubMed Web of Science ®Google Scholar
• Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–198.
   PubMed Web of Science ®Google Scholar
• Jack S, West MA, Raw D, et al. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery. Eur J Surg Oncol. 2014;40(10):1313–1320.
   PubMed Web of Science ®Google Scholar
• Nikniaz Z, Somi MH, Naghashi S. Malnutrition and weight loss as prognostic factors in the survival of patients with gastric cancer. Nutr Cancer. 2022;74:1–6.
   PubMed Web of Science ®Google Scholar
• Grundmann O, Yoon SL, Williams JJ. Cachexia in patients with gastrointestinal cancers: contributing factors, prevention, and current management approaches. EMJ Gastroenterol. 2020;9(1):62–70.
   Google Scholar
• Andreyev HJN, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503–509.
   PubMed Web of Science ®Google Scholar
• Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69(4):491–497.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Palliative care, vol. 2021; 2020. Available from: https://www.who.int/health-topics/palliative-care.
   Google Scholar
• Merchant SJ, Brogly SB, Booth CM, et al. Palliative care and symptom burden in the last year of life: a population-based study of patients with gastrointestinal cancer. Ann Surg Oncol. 2019;26(8):2336–2345.
   PubMed Web of Science ®Google Scholar
• Hui D, Kim SH, Roquemore J, et al. Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer. 2014;120(11):1743–1749.
   PubMed Web of Science ®Google Scholar
• Näppä U, Lindqvist O, Rasmussen BH, et al. Palliative chemotherapy during the last month of life. Ann Oncol off J Eur Soc Med Oncol. 2011;22(11):2375–2380.
   PubMed Web of Science ®Google Scholar
• Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17(6):505–509.
   PubMed Web of Science ®Google Scholar
• Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–1138.
   PubMed Web of Science ®Google Scholar
• Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315–321.
   PubMed Web of Science ®Google Scholar
• Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587–1591.
   PubMed Web of Science ®Google Scholar
• Hirvonen OM, Leskelä R-L, Grönholm L, et al. Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at Helsinki University Hospital: a historic cohort study. Acta Oncol. 2019;58(12):1699–1705.
   PubMed Web of Science ®Google Scholar
• Poulose JV, Do YK, Neo PSH. Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service. J Pain Symptom Manage. 2013;46(2):173–181.
   PubMed Web of Science ®Google Scholar
• Blackhall LJ, Read P, Stukenborg G, et al. CARE track for advanced cancer: impact and timing of an outpatient palliative care clinic. J Palliat Med. 2016;19(1):57–63.
   PubMed Web of Science ®Google Scholar
• Alsirafy SA, Raheem AA, Al-Zahrani AS, et al. Emergency department visits at the end of life of patients with terminal cancer: pattern, causes, and avoidability. Am J Hosp Palliat Care. 2016;33(7):658–662.
   PubMed Web of Science ®Google Scholar
• Nieder C, Tollåli T, Haukland E, et al. Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer. Support Care Cancer. 2016;24(10):4385–4391.
   PubMed Web of Science ®Google Scholar
• Hirvonen OM, Leskelä R-L, Grönholm L, et al. The impact of the duration of the palliative care period on cancer patients with regard to the use of hospital services and the place of death: a retrospective cohort study. BMC Palliat Care. 2020;19(1):37.
   PubMed Web of Science ®Google Scholar
• Guidelines for ethical review in human sciences. Finnish National Board on Research Integrity TENK [Internet]; 2021 [cited 2022 Jun 8]. Available from: https://tenk.fi/en/advice-and-materials/guidelines-ethical-review-human-sciences.
   Google Scholar
• Brooks GA, Abrams TA, Meyerhardt JA, et al. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014;32(6):496–503.
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncology: Gastric cancer 2.2021 [Internet]; 2021 [cited 2021 Nov 15]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
   Google Scholar
• NCCN Clinical Practice Guidelines in Oncology: Esophageal and esophagogastric junction cancers 2.2021 [Internet]; 2021 [cited 2021 Nov 15]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
   Google Scholar
• Cavanagh KE, Baxter MA, Petty RD. Best supportive care and prognosis: advanced gastroesophageal adenocarcinoma. BMJ Support Palliat Care. 2021. DOI:10.1136/bmjspcare-2020-002637
   PubMed Web of Science ®Google Scholar
• Hébuterne X, Lemarié E, Michallet M, et al. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38(2):196–204.
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.
   PubMed Web of Science ®Google Scholar
• Collins A, Sundararajan V, Burchell J, et al. Transition points for the routine integration of palliative care in patients with advanced cancer. J Pain Symptom Manage. 2018;56(2):185–194.
   PubMed Web of Science ®Google Scholar